SCHEMBL14940346

SCHEMBL14940346

COc1ccc(CN2CCN(C3(c4cccc(F)c4)Cc4cc(F)ccc4C3=O)CC2)cc1

nearest known ligand 0.44

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 2/20 0.44
DRD2 P14416 1/20 0.44
HTR2A P28223 1/20 0.44
HTR2C P28335 1/20 0.44
HTR2B P41595 1/20 0.44
OPRM1 P35372 1/20 0.43
OPRL1 P41146 1/20 0.43
ALDH1A1 P00352 1/20 0.42
POLB P06746 1/20 0.42
DRD4 P21917 1/20 0.42
TACR1 P25103 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14938869 0.94 SIGMAR1 (0.48) SIGMAR1DRD2HTR2AHTR2CHTR2B
SCHEMBL14940059 0.88 NPSR1 (0.49) SIGMAR1DRD2HTR2AHTR2CHTR2B
SCHEMBL14939568 0.86 OPRM1 (0.43) SIGMAR1DRD2HTR2AHTR2CHTR2B
SCHEMBL14940465 0.85 SIGMAR1 (0.50) SIGMAR1DRD2HTR2AHTR2CHTR2B
SCHEMBL14939880 0.83 NPSR1 (0.52) SIGMAR1DRD2HTR2AHTR2CHTR2B
SCHEMBL14939129 0.83 NPSR1 (0.46) SIGMAR1DRD2HTR2AHTR2CHTR2B
SCHEMBL14939526 0.83 NPSR1 (0.46) SIGMAR1DRD2HTR2AHTR2CHTR2B
SCHEMBL14939744 0.83 LMNA (0.45) SIGMAR1DRD2HTR2AHTR2CHTR2B
SCHEMBL14939844 0.83 NPSR1 (0.45) SIGMAR1DRD2HTR2AHTR2CHTR2B
SCHEMBL14939469 0.83 SIGMAR1 (0.50) SIGMAR1DRD2HTR2AHTR2CHTR2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2013068785-A1 INDANONE AND INDANDIONE DERIVATIVES AND HETEROCYCLIC ANALOGS ACTELION PHARMACEUTICALS LTD (CH) 2013-05-16 WO claimed
WO-2013068785-A1 INDANONE AND INDANDIONE DERIVATIVES AND HETEROCYCLIC ANALOGS ACTELION PHARMACEUTICALS LTD (CH) 2013-05-16 WO disclosed